BioCentriq - Ownership and Business Overview

Life ScienceCompany

BioCentriq Ownership

Who owns BioCentriq?

BioCentriq is owned by Green Cross Holdings. It was acquired on May 17, 2022.

BioCentriq Business Overview

Where is BioCentriq headquartered?

BioCentriq is headquartered in Newark, New Jersey.

What is BioCentriq’s revenue?

BioCentriq disclosed revenue of 1,840,558M KRW for 2021 and 1,719,325M KRW for 2020.

What sector is BioCentriq in?

BioCentriq is a life science company.

When was BioCentriq founded?

BioCentriq was founded in 2019.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 296 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 259 by strategics.

BioCentriq

Highlander Factory, Inc.

138 Summit Street,
Newark, New Jersey 07103
United States,
(973) 642-7999
www.biocentriq.com

BioCentriq is a US-based contract development and manufacturing organization (CDMO) that designs and develops scalable cell and gene technologies. BioCentriq was founded in 2019 and is based in Newark, New Jersey.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.